TRACK A - Future of Georgia:
Women Leading Patient Empowerment
According to AdvaMed, only 12 of AdvaMed’s more than 250 member companies are led by women. Women constitute only 12% of healthcare industry board directors. Women account for 73% of healthcare company managers but only 4% of CEOs.
Nevertheless, Fortune 500 companies with more than three women on the Board have 66% higher return on invested capital and a 42% higher return on sales.
Who is leading opportunities or innovations in life science by or for women and how?
Where are the areas of greatest need and opportunity? What does patient empowerment in life science innovation mean and how can women in life sciences raise the bar in outcomes and the standard of care?
Join Maital Guttman as she moderates this panel with Sherry Farrugia, Jayne Morgan, and Angela Fusaron to find out.
Maital Guttman, MBA
Global Inclusion & Diversity Manager, McKinsey & Company
Maital Guttman was born in Israel and grew up in North Carolina since the age of 12. After graduating from Duke University as a Robertson Scholar with a BA in International Studies, she founded a documentary film production company, Dewdrop Films LLC. Dewdrop Films produced and screened films around the world, including South Africa, Moldova, Israel and the US.She received an MBA from UNC Kenan-Flagler Business School in 2013 with a concentration in consulting and sustainable enterprise. She interned at and started as a consultant at McKinsey & Company, where she has focused on topics around economic development, innovation, strategy, culture, change management and talent management. She is currently serving as McKinsey’s head of diversity and inclusion in North America, working to create an environment that attracts, develops, and retains exceptional women and diverse talent. She lives with her wife, son and golden doodle in Atlanta.
Chief Operating and Strategy Officer, Children’s Healthcare of Atlanta Pediatric Technology Center
As the COO of the Pediatric Technology Center (PTC), Ms. Farrugia manages daily activities associated with the Center and the Georgia Tech/Children’s Healthcare of Atlanta partnership, and the overall execution of key business initiatives to improve efficiency, effectiveness and reduce administrative costs. She provides executive level leadership for business and operational functions such as budget planning and organization of team process around a function. This includes providing insight into the innovations, new technologies and start up developed as a result of the partnership. Prior to this position Ms. Farrugia was the Managing Director and Strategic Partners Office of Health IT at Georgia Tech. In this role she was responsible for developing the health IT strategy specifically as it relates to digital health, connecting faculty to health IT/digital health industry partners, and mentoring health IT and digital health startups.
Prior to joining Georgia Tech, Sherry owned a successful consulting company where she worked with healthcare companies advising them on new market opportunities, and launching new verticals, and worked with startups advising them on market strategy and business plan. She also co-founded and sold a health IT company to McKesson HBO & Company in the early ’90s whose technology was focused on point-of-care documentation and tracking both clinical and financial outcomes – technology McKesson is still using in their systems today.
Ms. Farrugia is currently an advisory board member of Technology Association of Georgia Health (TAG), Health Connect South, Atlanta Ronald McDonald House Charities, Metro Chamber, BioScience Leadership Council, MedTech Women@Semda, and Vice President of the International Society for Pediatric Innovation (iSPI).
Angela Fusaro, MD, MBA
CEO & Co-Founder, Physician 360
Angela Fusaro, MD, MBA, is an Emergency Medicine physician and Co-Founder and CEO of Physician 360™, a virtual urgent care company that helps patients avoid unnecessary in-person doctor visits.
A pioneer in healthcare innovation, Dr. Fusaro was recently a faculty member at the Emory University School of Medicine, where she designed and implemented two entrepreneurship courses for medical students and led a national workshop that helps physicians translate clinical insight into marketable products that can save, and improve the quality of patients' lives. She also has extensive leadership experience in organized medicine, previously driving business development for EMRA, the second largest Emergency Medicine organization in the world. She is a board member of numerous organizations, including Hygeia Health and Girls on the Run Atlanta. Dr. Fusaro received her MBA from Goizueta Business School and was a 2017 Poets & Quants recipient.
Jayne Morgan, MD
Director of Innovation and Research Development, Piedmont Healthcare
Jayne Morgan, M.D. is a Cardiologist and the Director of Innovation at the Piedmont Healthcare Corporation in Atlanta, GA. Within this role she is accountable for building an Innovation network within Piedmont, and democratizing innovation by identifying and aligning opportunities within the system for technology development and/or process improvement. She is also responsible for setting the vision, trajectory, and long term strategic scaling and sustainability for the Office of Innovation, as well as seeking key partnerships and stakeholders to progress these goals. Further, she is tasked with providing the internal infrastructure of the Office of Innovation, including the development of a systemwide Intellectual Property Policy, plus all needed contracts and templates. And finally, she serves to support the development of any and all internal Intellectual Property of Piedmont employees, and progress these projects within the incubator toward licensing or commercialization potential.
Prior to this role she had a split role as both the Director of Innovation and Director of Research Development where she had responsibility for the strategic growth of the Piedmont Research Institute, the development of the long range strategic vision for research programs across all medical specialties, and contract negotiations for all new partners. Dr. Morgan initially came to Piedmont in 2015 as the Director of Cardiovascular Research for the Piedmont Heart Institute. Within this role, she implemented a new business model focused on system integration, contracts, staff re-alignments, portfolio diversification, and strategic growth realizing steadily increasing revenue earnings that have continued to this day. While in this role, she both expanded research to other hospital facilities, and began the first Feasibility Program which has served as the nidus via which Piedmont has been able to reach worldwide status within Structural and Valvular Heart, including the #1 Center in the United States for transcatheter tricuspid therapy.
Prior to coming to Piedmont, Dr. Morgan served as the Chief Medical Officer of the American Chemistry Council (where she developed a new translational research program), a Cardiology Consultant at Abbott Vascular Devices Structural Heart Division (working with the Mitra-Clip team/U.S. and Europe), the World Wide Director of the Cardiorenal Drug Development program at Solvay Pharmaceuticals, and an Assistant Professor of Medicine at the Cleveland Clinic.
Dr. Morgan currently serves as the President Elect of the Southeastern Medical Device Association (SEMDA), Co-Chair of the Health and Human Services Conference 2021, Founding Board Member of MedTech Women, Co-Chair of the BioScience Leadership Council at the Metro Atlanta Chamber of Commerce, Board Member of the American Heart Association/Atlanta Chapter, the National Board Member of The American Heart Association Technology Team, the Regional Board Member of The American Heart Association Health Equity Committee, and is an active member of BioMed Investors Network.
Dr. Morgan completed her B.S. degree at Spelman College (C’84), Medical Degree at Michigan State University, Internal Medicine Residency at George Washington University, and both her Cardiology and Pacemaker Fellowship at Mount Sinai Medical Center.